167 related articles for article (PubMed ID: 33155199)
1. LncRNA NORAD stimulates proliferation and migration of renal cancer via activating the miR-144-3p/MYCN axis.
Zhao W; Wang L; Xu F
Eur Rev Med Pharmacol Sci; 2020 Oct; 24(20):10426-10432. PubMed ID: 33155199
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA NORAD promotes the occurrence and development of non-small cell lung cancer by adsorbing MiR-656-3p.
Chen T; Qin S; Gu Y; Pan H; Bian D
Mol Genet Genomic Med; 2019 Aug; 7(8):e757. PubMed ID: 31207175
[TBL] [Abstract][Full Text] [Related]
3. Regulatory mechanism of lncRNA NORAD on proliferation and invasion of ovarian cancer cells through miR-199a-3p.
Xu C; Zhu LX; Sun DM; Yao H; Han DX
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1672-1681. PubMed ID: 32141533
[TBL] [Abstract][Full Text] [Related]
4. LncRNA NORAD accelerates the progression and doxorubicin resistance of neuroblastoma through up-regulating HDAC8 via sponging miR-144-3p.
Wang B; Xu L; Zhang J; Cheng X; Xu Q; Wang J; Mao F
Biomed Pharmacother; 2020 Sep; 129():110268. PubMed ID: 32563146
[TBL] [Abstract][Full Text] [Related]
5. LncRNA NORAD, sponging miR-363-3p, promotes invasion and EMT by upregulating PEAK1 and activating the ERK signaling pathway in NSCLC cells.
Geng Q; Li Z; Li X; Wu Y; Chen N
J Bioenerg Biomembr; 2021 Jun; 53(3):321-332. PubMed ID: 33742335
[TBL] [Abstract][Full Text] [Related]
6. LncRNA NORAD targets miR-410-3p to regulate drug resistance sensitivity of osteosarcoma.
Xie X; Liu W; Duan Z; Li X; Zhang L; Yang G
Cell Mol Biol (Noisy-le-grand); 2020 Jun; 66(3):143-148. PubMed ID: 32538761
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA NORAD inhibition upregulates microRNA-323a-3p to suppress tumorigenesis and development of breast cancer through the PUM1/eIF2 axis.
Shi P; Zhang J; Li X; Li W; Li H; Fu P
Cell Cycle; 2021 Jul; 20(13):1295-1307. PubMed ID: 34125645
[TBL] [Abstract][Full Text] [Related]
8. Long noncoding RNA NORAD regulates cancer cell proliferation and migration in human osteosarcoma by endogenously competing with miR-199a-3p.
Wang X; Zou J; Chen H; Zhang P; Lu Z; You Z; Sun J
IUBMB Life; 2019 Oct; 71(10):1482-1491. PubMed ID: 31169973
[TBL] [Abstract][Full Text] [Related]
9. LncRNA NORAD Mediates the Proliferation and Apoptosis of Diffuse Large-B-Cell Lymphoma via Regulation of miR-345-3p/TRAF6 Axis.
Li Y; Lv Y; Wang J; Zhu X; Chen J; Zhang W; Wang C; Jiang L
Arch Med Res; 2022 Apr; 53(3):271-279. PubMed ID: 35164979
[TBL] [Abstract][Full Text] [Related]
10. NORAD accelerates chemo-resistance of non-small-cell lung cancer via targeting at miR-129-1-3p/SOX4 axis.
Huang Q; Xing S; Peng A; Yu Z
Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31894841
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of long non-coding RNA XIST inhibits cell proliferation, migration, invasion and EMT by regulating miR-212-3p/CBLL1 axis in non-small cell lung cancer cells.
Qiu HB; Yang K; Yu HY; Liu M
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8391-8402. PubMed ID: 31646569
[TBL] [Abstract][Full Text] [Related]
12. SP1-induced HOXD-AS1 promotes malignant progression of cholangiocarcinoma by regulating miR-520c-3p/MYCN.
Li J; Jiang X; Li Z; Huang L; Ji D; Yu L; Zhou Y; Cui Y
Aging (Albany NY); 2020 Aug; 12(16):16304-16325. PubMed ID: 32857725
[TBL] [Abstract][Full Text] [Related]
13. LncRNA NORAD promotes proliferation, migration and angiogenesis of hepatocellular carcinoma cells through targeting miR-211-5p/FOXD1/VEGF-A axis.
Sun DS; Guan CH; Wang WN; Hu ZT; Zhao YQ; Jiang XM
Microvasc Res; 2021 Mar; 134():104120. PubMed ID: 33309645
[TBL] [Abstract][Full Text] [Related]
14. Propofol Ameliorates the Proliferation and Epithelial-Mesenchymal Transition of Hepatoma Carcinoma Cells via Non-Coding RNA Activated by DNA Damage (NORAD)/microRNA (miR)-556-3p/Migration and Invasion Enhancer 1 (MIEN1) Axis.
Liu Y; Wang X; Li H; Guan E; Luo K
J Environ Pathol Toxicol Oncol; 2021; 40(4):87-97. PubMed ID: 34936303
[TBL] [Abstract][Full Text] [Related]
15. BMSC-EV-derived lncRNA NORAD Facilitates Migration, Invasion, and Angiogenesis in Osteosarcoma Cells by Regulating CREBBP
Feng D; Li Z; Yang L; Liang H; He H; Liu L; Zhang W
Oxid Med Cell Longev; 2022; 2022():8825784. PubMed ID: 35281474
[TBL] [Abstract][Full Text] [Related]
16. LncRNA NORAD promotes the progression of myocardial infarction by targeting the miR-22-3p/PTEN axis.
Li C; Zhang L; Bu X; Chu G; Zhao X; Liu Y
Acta Biochim Biophys Sin (Shanghai); 2022 Apr; 54(4):463-473. PubMed ID: 35607965
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA NORAD promotes the prostate cancer cell extracellular vesicle release via microRNA-541-3p-regulated PKM2 to induce bone metastasis of prostate cancer.
Hu CY; Chen J; Qin XH; You P; Ma J; Zhang J; Zhang H; Xu JD
J Exp Clin Cancer Res; 2021 Mar; 40(1):98. PubMed ID: 33722248
[TBL] [Abstract][Full Text] [Related]
18. NORAD regulates proliferation and apoptosis in cardiomyocytes under high-glucose treatment through miRNA-150-5p/ZEB1 axis.
Han Y; Tian H; Gao X
Eur Rev Med Pharmacol Sci; 2020 Nov; 24(21):11259-11265. PubMed ID: 33215445
[TBL] [Abstract][Full Text] [Related]
19. LINC01857 Exacerbates the Malignant Behaviors of Endometrial Carcinoma Cells by Sponging miR-19b-3p and Recruiting ELAVL1 to Upregulate MYCN.
Cao R; Zhao J; Zhang J
Gynecol Obstet Invest; 2023; 88(1):16-29. PubMed ID: 36574754
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA-non-coding RNA activated by DNA damage inhibition suppresses hepatic stellate cell activation via microRNA-495-3p/sphingosine 1-phosphate receptor 3 axis.
Zou L; Shi C; Wang D; Cheng J; Wang Q; Wang L; Yang G
Bioengineered; 2022 Mar; 13(3):6150-6162. PubMed ID: 35200103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
